Q2 revenue up 15% to $16.9M, EPS $0.53 diluted vs $0.40 YoY

FITLIFE BRANDS, INC.

2024-Q2 EPS reported $0.97 revenue$33,479,000

Revenue $16.9M (+15% YoY); net income $2.6M, diluted EPS $0.53.
Adjusted EBITDA $3.8M (+29% YoY); gross margin expanded to 44.8% from 40.4%.
Online sales $11.2M (66% of revenue, +13% YoY); wholesale $5.7M (+18%).
MusclePharm revenue $2.7M, up 27% sequentially; MRC contribution $2.5M (+61% YoY).
New director Matt Lingenbrink elected; cash $4.4M, net debt $11.7M (0.9x adj. EBITDA).

item 2.02 item 5.02 item 5.07 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matt Lingenbrink

Director

FTLF · FITLIFE BRANDS, INC.

Effective: 2024-08-13
Filed: August 14, 2024, 7:59 PM ET

At the Annual Meeting, the Company’s stockholders elected Matt Lingenbrink to serve as a member of the Board of Directors of the Company until the Company’s next annual meeting of stockholders or until his successor is duly elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matt Lingenbrink was elected as Director at FITLIFE BRANDS, INC..

Action: elected
Role: Director

Exact text from the filing

At the Annual Meeting, the Company’s stockholders elected Matt Lingenbrink to serve as a member of the Board of Directors of the Company until the Company’s next annual meeting of stockholders or until his successor is duly elected and qualified.

View on SEC.gov

FITLIFE BRANDS, INC. filing history →

Source: SEC EDGAR

accession 0001437749-24-026822

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.